Skip to content

File Analysis of Falling Patients: Are Drugs Frequently Involved

File Analysis of Falling Patients: Are Drugs Frequently Involved

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04787146
Acronym
ADOPAC
Enrollment
52
Registered
2021-03-08
Start date
2019-04-18
Completion date
2021-02-28
Last updated
2021-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fall Patients

Keywords

Drugs

Brief summary

The damage caused by patient falls is a major public health problem, due to the large and growing number of people concerned, the potentially serious consequences but also the financial cost generated by their care. These consequences can be physical as well as psychological. Fractures and pain are the first consequences that come to mind, but many others should be mentioned: post-fall syndrome, loss of autonomy or even entering an institution, fear of falling, loss of confidence in itself.

Detailed description

During 2018, 285 reports of falls were counted within the Paris Saint-Joseph Hospital Group (GhPSJ). Reducing these falls is one of the institutional goals. A dedicated working group has been created to put in place preventive and corrective measures. These falls can be caused by many factors to the patient: 1. Intrinsic: * History of a fall, * pathologies (Parkinson's or Alzheimer's disease), * hearing and visual disturbances, * urinary incontinence. 2. extrinsic: * Unsuitable shoes * unsuitable habitat, * slippery floors (eg bathroom). Among the intrinsic factors, polypharmacy is also found. It has been established that certain drug classes are at risk of falling, in particular psychotropic drugs (benzodiazepines, hypnotics, anxiolytics, antidepressants, neuroleptics) which promote sedation and dizziness, hypoglycemic drugs which cause hypoglycaemia in diabetic patients on -treated or antihypertensive drugs causing hypotension. It is now clearly established that drug adherence to treatment is poor in cities, giving rise to omissions but also sometimes to overconsumption of certain drugs, including psychotropic drugs.

Interventions

OTHERNo intervention

Once the patient is included, a drug assessment is carried out as part of the treatment and then an compliance questionnaire is submitted to him.

Sponsors

Fondation Hôpital Saint-Joseph
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Major patient * French-speaking patient * Patient hospitalized within the Paris Saint-Joseph Hospital Group * Patient who fell during hospitalization and for whom a fall report has been completed

Exclusion criteria

* Patients in the process of therapeutic limitation * Patient under guardianship or curatorship * Patient deprived of liberty * Patient objecting to participation in the study * Patient under legal protection

Design outcomes

Primary

MeasureTime frameDescription
To assess the prevalence of falls associated with one or more risk factors for drug iatrogenism within the Paris Saint-Joseph Hospital Group.1 weekPercentage of falls involving one or more drugs at risk of falling

Secondary

MeasureTime frameDescription
List the drug treatments at risk taken by patients who fall1 weekTo list the drug treatments taken by the patients who fall: carrying out the patient's drug assessment
Evaluate the relevance of drug prescriptions in patients who fall1 weekAverage number of inappropriate medication prescriptions per patient
Evaluate the overall compliance of falling patients1 weekAverage compliance score in patients who fall

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026